Nierman Practice Management (NPM) announces a new faculty lineup along with the release of its 2024 dental CE course schedule for dental sleep medicine, TMD, and medical billing in dentistry.
JUPITER, Fla.,Dec. 4, 2023
/PRNewswire-PRWeb/ -- Nierman Practice Management (NPM) is thrilled to
announce the release of its 2024 dental CE course schedule, featuring
nine engaging courses focused on dental sleep medicine,
temporomandibular joint (TMJ) disorders, and medical billing in
dentistry implementation.Nierman CE courses empower dental professionals to add
and grow obstructive sleep apnea (OSA) and TMJ disorders treatment into
their practices. The programs also guide dentists and the dental team
in navigating their patients ' medical insurance to optimize
reimbursement for these services.The diverse cours...
Source: Dental Technology Blog - December 13, 2023 Category: Dentistry Source Type: news
Users of recalled Philips CPACs can now claim settlement
People who have bought, leased or rented certain Philips Respironics sleep apnea machines can now file a claim for restitution. The Dutch medical equipment maker recently agreed to pay at least $479 million to compensate users of 20 different breathing devices and ventilators sold in the United…#philipsrespironics #dutch #fda #philips #adevice #usdistrictcourt #westerndistrict #pennsylvania (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news
Short Sleep Duration Linked to All-Cause Mortality in Apnea Patients
TUESDAY, Dec. 5, 2023 -- For patients with obstructive sleep apnea (OSA), those sleeping less than seven hours have increased risk of all-cause mortality, according to a study published online Dec. 5 in JAMA Network Open.Yiqi Lin, M.D., from Fujian... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2023 Category: Pharmaceuticals Source Type: news
Early Surgery for Kids' Mild Sleep Apnea Doesn't Boost Executive Function
(MedPage Today) -- For children with habitual snoring and mild sleep apnea, early adenotonsillectomy did not improve executive function or attention compared with watchful waiting, a randomized clinical trial showed.
Average improvement in executive... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - December 5, 2023 Category: Pediatrics Source Type: news
Tonsil, Adenoid Removal Improved Sleep Quality, Some Behavioral Problems in Children with Mild Sleep Apnea
In a randomized clinical trial, a team led by researchers at Brigham and Women ’s Hospital, in collaboration with the Harvard Pilgrim Health Care Institute, evaluated the effects of early adenotonsillectomy. (Source: BWH News)
Source: BWH News - December 5, 2023 Category: Hospital Management Source Type: news
A pediatric patient with severe obstructive sleep apnea and comorbid depression and substance abuse - Leconte CE, Ng JW, Manzardo AM, Douglass MM.
Obstructive sleep apnea (OSA), depression, and substance abuse problems share similar symptomatology and have significant interplay. An underlying diagnosis of OSA can often be overlooked in patients with significant psychiatric illness and polysubstance u... (Source: SafetyLit)
Source: SafetyLit - December 4, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Tonsil, Adenoid Removal Improved Sleep Quality, Some Behavioral Problems in Children with Mild Sleep Apnea
In a randomized clinical trial, a team led by researchers at Brigham and Women ’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with the Harvard Pilgrim Health Care Institute, evaluated the effects of earl (Source: BWH News)
Source: BWH News - December 4, 2023 Category: Hospital Management Source Type: news
Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
None Vivos Therapeutics has received 510(k) clearance for the use of its oral devices in adults with severe obstructive sleep apnea (OSA). • None The Food and Drug Administration ruling, which comes 11 months after Vivos received clearance for an oral appliance in mild-to-moderate OSA, gives the…#nonevivos #osa #vivos #fda #philips #kirkhuntsman #medicare #medtechdive (Source: Reuters: Health)
Source: Reuters: Health - November 30, 2023 Category: Consumer Health News Source Type: news
FDA Clears First Oral Device Treatment for Severe Sleep Apnea
(MedPage Today) -- The FDA cleared the first oral appliances for treating severe obstructive sleep apnea (OSA), Vivos Therapeutics announced on Wednesday.
The removable complete airway repositioning and/or expansion (CARE) line of oral appliances... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 30, 2023 Category: American Health Source Type: news
FDA Warns That Philips' CPAP Machines May Overheat
(MedPage Today) -- Philips DreamStation 2 continuous positive airway pressure (CPAP) machines for sleep apnea may overheat, according to an FDA safety alert on Tuesday urging patients to monitor their devices.
"The FDA recently received medical... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 30, 2023 Category: American Health Source Type: news
Vivos Therapeutics ’ stock soars as sleep apnea device gets regulatory clearance
Vivos Therapeutics Inc. shares VVOS jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleep apnea. The U.S. Food and Drug Administration gave a green light for Vivos CARE appliances to treat severe…#vivostherapeuticsinc #vvos (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2023 Category: Consumer Health News Source Type: news
UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea
Vivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally in the company's shares before the bell. Shares of the medical device maker more than doubled to $9.12 in premarket trading. The clearance is…#vivostherapeutics #philips #fda #bengaluru #shilpimajumdar (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2023 Category: Consumer Health News Source Type: news
FDA Flags New Problem With Philips Machines, Shares Fall FDA Flags New Problem With Philips Machines, Shares Fall
The FDA said it is alerting patients of a new safety issue with machines made by the group that are used for the treatment of obstructive sleep apnea.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2023 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Philips Stock Falls Nearly 5% After FDA Issues Safety Warning About Its Sleep Apnea Machines
The FDA warned that Philips Sleep Apnea machines should be closely monitored for signs of overheating. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 29, 2023 Category: Pharmaceuticals Authors: Siladitya Ray, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news
Philips Sleep Apnea Machine Safety Fears Grow; Shares Slump
(Source: Reuters: Health)
Source: Reuters: Health - November 29, 2023 Category: Consumer Health News Source Type: news
